{"id":"W4289815058","doi":"10.36469/001c.36976","title":"Chronic Myeloid Leukemia: Part II—Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective","year":2022,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"Novartis Pharmaceuticals Corporation","keywords":"Myeloid leukemia; Perspective (graphical); Medicine; Phase (matter); Intensive care medicine; Internal medicine; Chemistry; Computer science; Artificial intelligence","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006535106,0.0003331622,0.0002987897,0.001307655,0.000308709,0.001305882,0.000396797,0.0005339745,0.002958541],"category_scores_gemma":[0.002578636,0.0002195555,0.0009623056,0.003915197,0.000235013,0.0008603479,0.0007686049,0.0008982362,0.0001599597],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003709543,"about_ca_system_score_gemma":0.001426392,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0503214,"about_ca_topic_score_gemma":0.05267385,"domain_scores_codex":[0.9992096,0.0002300718,0.0001240155,0.0001004349,0.0001805563,0.0001552382],"domain_scores_gemma":[0.9980273,0.0002162284,0.001293526,0.00003033014,0.0001761886,0.0002564898],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001404736,0.00009840592,0.9706156,0.0001821277,0.0003646752,0.0001027037,0.0001241197,0.001553136,0.00008969588,0.001433406,0.01244904,0.01284659],"study_design_scores_gemma":[0.00002460495,0.00006490999,0.99041,0.0002239646,0.0001050288,0.0002556188,0.0006168684,0.002687056,0.00005108627,0.0004082457,0.005141166,0.00001145208],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9265616,0.01577584,0.000403872,0.0113288,0.0001840436,0.0001341955,0.03990741,0.00001673798,0.005687529],"genre_scores_gemma":[0.9805781,0.00524418,0.0003178594,0.001074511,0.0002050855,0.0001102792,0.0119632,0.000005581868,0.0005013487],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0503214,"threshold_uncertainty_score":0.100057,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06831243107343316,"score_gpt":0.4248905147898626,"score_spread":0.3565780837164295,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}